Service User and Staff Views on Digital Remote Monitoring for Psychosis
NCT ID: NCT05670197
Last Updated: 2024-11-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
118 participants
OBSERVATIONAL
2022-11-01
2024-01-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Smartphones and other digital technologies are now widespread. This offers a solution to help tackle the overwhelming demand on services and to enable people with psychosis to access mental health support when they need it most (e.g. when relapsing). Research shows that people with psychosis are often willing to report their symptoms using a smartphone app. Apps like this can alert health professionals when someone needs extra support, but can be burdensome to use long-term. The investigators want to make a system that is less burdensome and is personalised to users' needs and experiences (a 'complex digital remote monitoring system'). Recent research shows that information gathered routinely by individuals' smartphones (e.g. GPS, step count) might help predict relapses of psychosis. The investigators want to use this method in a complex digital remote monitoring system. First, the investigators need to know what people with psychosis and mental health staff think about this idea.
The investigators will interview around sixty adults with psychosis and around forty staff, recruited from UK mental health services (Manchester, Glasgow, Edinburgh, Cardiff, London, Sussex). These one-off, audio-recorded interviews will last up to 60 minutes. The interviewer will ask about participants' views on complex digital remote monitoring. The investigators will then systematically analyse the interviews. Findings will inform the design of the investigators' own complex digital remote monitoring system and future digital tools designed by other researchers. NIHR and Wellcome are funding this study.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
E-Detection Tool for Emerging Mental Disorders
NCT05127278
Psychosis: Early Detection, Intervention and Prevention
NCT01597141
Piloting of an Intervention to Reduce Problematic Alcohol Use in Early Phase Psychosis Patients
NCT05365347
Focus Groups on Cognitive Function in Psychosis
NCT06364241
mHealth for Psychosis Help-seeking
NCT05905601
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Service users
Service users with experience of schizophrenia spectrum psychosis
No intervention. Participants will take part in a qualitative interview
No intervention. Participants will take part in a one-off, audio-recorded qualitative interview, lasting up to 60 minutes. The interviewer will ask about participants' views on complex digital remote monitoring.
Mental health staff
Mental health staff who work within an adult NHS service providing mental health support to people who experience schizophrenia spectrum psychosis / severe mental health problems
No intervention. Participants will take part in a qualitative interview
No intervention. Participants will take part in a one-off, audio-recorded qualitative interview, lasting up to 60 minutes. The interviewer will ask about participants' views on complex digital remote monitoring.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention. Participants will take part in a qualitative interview
No intervention. Participants will take part in a one-off, audio-recorded qualitative interview, lasting up to 60 minutes. The interviewer will ask about participants' views on complex digital remote monitoring.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* In contact with mental health services
* Over 16 years of age
* Ability to give informed consent
* Work within an adult NHS service providing mental health support to people who experience psychosis / severe mental health problems
* Ability to give informed consent
Exclusion Criteria
* Not sufficiently fluent in English to take part in an interview
STAFF PARTICIPANTS
\- Not sufficiently fluent in English to take part in an interview
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Glasgow
OTHER
University of Edinburgh
OTHER
King's College London
OTHER
Cardiff University
OTHER
University of Sussex
OTHER
Manchester Academic Health Science Centre
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sandra Bucci
Professor Sandra Bucci
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sandra Bucci, ClinPsyD
Role: STUDY_CHAIR
University of Manchester
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Manchester
Manchester, Greater Manchester, United Kingdom
University of Sussex
Brighton, , United Kingdom
Cardiff University
Cardiff, , United Kingdom
University of Edinburgh
Edinburgh, , United Kingdom
University of Glasgow
Glasgow, , United Kingdom
King's College London
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NHS001961
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.